Growing old with nuclear factor-κB

Cell Stress and Chaperones

Volumn 7, Issue 2, 2002, Pages 207-212

  Giardina, Charles ^a   Hubbard, Andrea K ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

AGING; CARCINOGENESIS; CELL DEATH; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GERIATRIC DISORDER; IMMUNE RESPONSE; LIFESPAN; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

AGING; ANIMALS; CELL DEATH; HUMANS; MICE; NF-KAPPA B;

ANIMALIA; MAMMALIA;

EID: 0036556686     PISSN: 13558145     EISSN: None     Source Type: Journal    
DOI: 10.1379/1466-1268(2002)007<0207:GOWNFB>2.0.CO;2     Document Type: Review

References (82)

1. Aljada A, Ghanim H, Assian E, Mohanty P, Hamouda W, Garg R, Dandona P. 1999. Increased IkappaB expression and diminished nuclear NF-kappaB in human mononuclear cells following hydrocortisone injection. J Clin Endocrinol Metab 84: 3386-3389.
2. Ames BN. 1989. Endogenous oxidative DNA damage, aging, and cancer. Free Radic Res Commun 7: 121-128.
3. Aspinall R, Andrew D. 2000. Thymic involution in aging. J Clin Immunol 20: 250-256.
4. Baldwin AS. 2001a. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Investig 107: 241-246.
5. Baldwin AS, Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683.
6. Baldwin AS, Jr. 2001b. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Investig 107: 3-6.
7. Barger SW, Horster D, Furukawa K, Goodman Y, Krieglstein J, Mattson MP. 1995. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci U S A 92: 9328-9332.
8. Beckman KB, Ames BN. 1998. The free radical theory of aging matures. Physiol Rev 78: 547-581.
9. Beg AA, Baltimore D. 1996. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274: 782-784.
10. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376: 167-170.
11. Behl C, Davis JB, Lesley R, Schubert D. 1994. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77: 817-827.
12. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34.
13. Boissiere F, Hunot S, Faucheux B, Duyckaerts C, Hauw JJ, Agid Y, Hirsch EC. 1997. Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease. Neuroreport 8: 2849-2852.
14. Breimer LH. 1990. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Mol Carcinog 3: 188-197.
15. Brown K, Park S, Kanno T, Franzoso G, Siebenlist U. 1993. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci U S A 90: 2532-2536.
16. Butcher S, Chahel H, Lord JM. 2000. Review article: ageing and the neutrophil: no appetite for killing? Immunology 100: 411-416.
17. Chan H, Bartos DP, Owen-Schaub LB. 1999. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment. Mol Cell Biol 19: 2098-2108.
18. De Bosscher K, Vanden Berghe W, Vermeulen L, Plaisance S, Boone E, Haegeman G. 2000. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci U S A 97: 3919-3924.
19. Effros RB, Pawelec G. 1997. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? Immunol Today 18: 450-454.
20. Esterbauer H, Schaur RJ, Zollner H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128.
21. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
22. Finkel T, Holbrook NJ. 2000. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247.
23. Fulop T, Jr, Foris G, Worum I, Leovey A. 1985. Age-dependent alterations of Fc gamma receptor-mediated effector functions of human polymorphonuclear leucocytes. Clin Exp Immunol 61: 425-432.
24. Geokas MC, Conteas CN, Majumdar AP. 1985. The aging gastrointestinal tract, liver, and pancreas. Clin Geriatr Med 1: 177-205.
25. Goya RG, Castro MG, Sosa YE. 1989. Diminished diurnal secretion of corticosterone in aging female but not male rats. Gerontology 35: 181-187.
26. Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, Cato AC. 1997. I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J 16: 4698-4707.
27. Helenius M, Hanninen M, Lehtinen SK, Salminen A. 1996a. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-kB transcription factor in mouse cardiac muscle. J Mol Cell Cardiol 28: 487-498.
28. Helenius M, Hanninen M, Lehtinen SK, Salminen A. 1996b. Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B. Biochem J 318(Pt 2): 603-608.
29. Helenius M, Kyrylenko S, Vehvilainen P, Salminen A. 2001. Characterization of aging-associated up-regulation of constitutive nuclear factor-kappa B binding activity. Antioxid Redox Signal 3: 147-156.
30. Hill WD, Hess DC, Carroll JE, et al. 2001. The NF-kappaB inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemia. Brain Res Bull 55: 375-386.
31. Ikeda A, Sun X, Li Y, et al. 2000. p300/CBP-dependent and -independent transcriptional interference between NF-kappaB RelA and p53. Biochem Biophys Res Commun 272: 375-379.
32. Imami N, Aspinall R, Gotch F. 2000. Role of the thymus in T lymphocyte reconstitution. Transplantation 69: 2238-2239.
33. Ivanov VN, Lee RK, Podack ER, Malek TR. 1997. Regulation of Fasdependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF-kappa B. Oncogene 14: 2455-2464.
34. Janssen-Heininger YM, Poynter ME, Baeuerle PA. 2000. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med 28: 1317-1327.
35. Jolly CA, Muthukumar A, Avula CP, Troyer D, Fernandes G. 2001. Life span is prolonged in food-restricted autoimmune-prone (NZB x NZW)F(1) mice fed a diet enriched with (n-3) fatty acids. J Nutr 131: 2753-2760.
36. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C. 1997. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A 94: 2642-2647.
37. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91: 649-659.
38. Kane LP, Shapiro VS, Stokoe D, Weiss A. 1999. Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol 9: 601-604.
39. Kasibhatla S, Genestier L, Green DR. 1999. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. J Biol Chem 274: 987-992.
40. Kim HJ, Kim KW, Yu BP, Chung HY. 2000. The effect of age on cyclooxygenase-2 gene expression: NF-kappaB activation and IkappaBalpha degradation. Free Radic Biol Med 28: 683-692.
41. Kizaki T, Ookawara T, Iwabuchi K, et al. 2000. Age-associated increase of basal corticosterone levels decreases ED2high, NF-kappaBhigh activated macrophages. J Leukoc Biol 68: 21-30.
42. Korhonen P, Helenius M, Salminen A. 1997. Age-related changes in the regulation of transcription factor NF-kappa B in rat brain. Neurosci Lett 225: 61-64.
43. Lin KI, DiDonato JA, Hoffmann A, Hardwick JM, Ratan RR. 1998. Suppression of steady-state, but not stimulus-induced NF-kappaB activity inhibits alphavirus-induced apoptosis. J Cell Biol 141: 1479-1487.
44. Lin KI, Lee SH, Narayanan R, Baraban JM, Hardwick JM, Ratan RR. 1995. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J Cell Biol 131: 1149-1161.
45. Linskens MH, Harley CB, West MD, Campisi J, Hayflick L. 1995. Replicative senescence and cell death. Science 267: 17.
46. Loft S, Deng XS, Tuo J, Wellejus A, Sorensen M, Poulsen HE. 1998. Experimental study of oxidative DNA damage. Free Radic Res 29: 525-539.
47. Loft S, Poulsen HE. 1996. Cancer risk and oxidative DNA damage in man. J Mol Med 74: 297-312.
48. Lord JM, Butcher S, Killampali V, Lascelles D, Salmon M. 2001. Neutrophil ageing and immunesenescence. Mech Ageing Dev 122: 1521-1535.
49. Madrid LV, Mayo MW, Reuther JY, Baldwin AS, Jr. 2001. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276: 18934-18940.
50. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS, Jr, Mayo MW. 2000. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 20: 1626-1638.
51. Matsui K, Fine A, Zhu B, Marshak-Rothstein A, Ju ST. 1998. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J Immunol 161: 3469-3473.
52. Mayo MW, Baldwin AS. 2000. The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 1470: M55-M62.
53. Miller RA. 1996. The aging immune system: primer and prospectus. Science 273: 70-74.
54. Miller RA. 2000. Telomere diminution as a cause of immune failure in old age: an unfashionable demurral. Biochem Soc Trans 28: 241-245.
55. Orr WC, Sohal RS. 1994. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 263: 1128-1130.
56. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. 1999. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85.
57. Place RF, Haspeslagh D, Hubbard AK, Giardina C. 2001. Cytokineinduced stabilization of newly synthesized I(kappa)B-alpha. Biochem Biophys Res Commun 283: 813-820.
58. Ponnappan U, Trebilcock GU, Zheng MZ. 1999a. Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on NFkappaB activation in T lymphocytes during aging: evidence for altered IkappaB-alpha phosphorylation and degradation. Exp Gerontol 34: 95-107.
59. Ponnappan U, Zhong M, Trebilcock GU. 1999b. Decreased proteasome-mediated degradation in T cells from the elderly: a role in immune senescence. Cell Immunol 192: 167-174.
60. Ritchie ME. 1998. Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris. Circulation 98: 1707-1713.
61. Romashkova JA, Makarov SS. 1999. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 86-90.
62. Ryan KM, Ernst MK, Rice NR, Vousden KH. 2000. Role of NF-kappaB in p53-mediated programmed cell death. Nature 404: 892-897.
63. Schreck R, Albermann K, Baeuerle PA. 1992. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells [a review]. Free Radic Res Commun 17: 221-237.
64. Schreck R, Rieber P, Baeuerle PA. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10: 2247-2258.
65. Sen R, Baltimore D. 1986a. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716.
66. Sen R, Baltimore D. 1986b. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47: 921-928.
67. Singh H, Sen R, Baltimore D, Sharp PA. 1986. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature 319: 154-158.
68. Sizemore N, Leung S, Stark GR. 1999. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol 19: 4798-4805.
69. Sonntag WE, Goliszek AG, Brodish A, Eldridge JC. 1987. Dimin ished diurnal secretion of adrenocorticotropin (ACTH), but not corticosterone, in old male rats: possible relation to increased adrenal sensitivity to ACTH in vivo. Endocrinology 120: 2308-2315.
70. Spaulding CC, Walford RL, Effros RB. 1997. The accumulation of non-replicative, non-functional, senescent T cells with age is avoided in calorically restricted mice by an enhancement of T cell apoptosis. Mech Ageing Dev 93: 25-33.
71. Spencer NF, Poynter ME, Im SY, Daynes RA. 1997. Constitutive activation of NF-kappa B in an animal model of aging. Int Immunol 9: 1581-1588.
72. Strauss E. 2001. Longevity. Growing old together. Science 292: 41-43.
73. Terai K, Matsuo A, McGeer EG, McGeer PL. 1996. Enhancement of immunoreactivity for NF-kappa B in human cerebral infarctions. Brain Res 739: 343-349.
74. Trebilcock GU, Ponnappan U. 1996. Evidence for lowered induction of nuclear factor kappa B in activated human T lymphocytes during aging. Gerontology 42: 137-146.
75. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. 1996. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274: 787-789.
76. Waddick KG, Uckun FM. 1999. Innovative treatment programs against cancer: II. Nuclear factor-kappaB (NF-kappaB) as a molecular target. Biochem Pharmacol 57: 9-17.
77. Wang CY, Mayo MW, Baldwin AS, Jr. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274: 784-787.
78. Webster GA, Perkins ND. 1999. Transcriptional cross talk between NF-kappaB and p53. Mol Cell Biol 19: 3485-3495.
79. Wissink S, van Heerde EC, Schmitz ML, Kalkhoven E, van der Burg B, Baeuerle PA, van der Saag PT. 1997. Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor. J Biol Chem 272: 22278-22284.
80. Wissink S, van Heerde EC, van der Burg B, van der Saag PT. 1998. A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids. Mol Endocrinol 12: 355-363.
81. Xiao ZQ, Majumdar AP. 2000. Induction of transcriptional activity of AP-1 and NF-kappaB in the gastric mucosa during aging. Am J Physiol Gastrointest Liver Physiol 278: G855-G865.
82. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 12: 2424-2433.